Literature DB >> 11986276

Animal model of Mycoplasma pneumoniae infection using germfree mice.

Masayuki Hayakawa1, Haruhiko Taguchi, Shigeru Kamiya, Yasunori Fujioka, Hidehiro Watanabe, Shin Kawai, Hiroyuki Kobayashi.   

Abstract

We have attempted to establish a gnotobiotic mouse model monoassociated with Mycoplasma pneumoniae following single or repeated infection to examine the mechanism of pathogenesis following M. pneumoniae infection. M. pneumoniae inoculated into germfree mice colonized equally well at 10(5) CFU/lung in both single infection and repeated infection. In histopathological observation, repeatedly infected mice showed pneumonia with mild infiltration of mononuclear cells and macrophages. Antibody titers against M. pneumoniae rose in the repeatedly infected mice but not in the singly infected mice. The percentage of CD4-positive, CD8-positive, and CD25-positive lymphocytes infiltrated in the lung was increased in the repeatedly infected mice. In contrast, the lymphocyte subset in the spleen was not significantly different among mock-, singly, and repeatedly infected mice. In the study of cytokine productivity of spleen cells, production of interleukin (IL)-4 and IL-10 was significantly increased and that of gamma interferon was remarkably increased in the mice following repeated infection. These results indicate that a gnotobiotic mouse model monoassociated with M. pneumoniae was established and that immune mechanisms might be involved in the pathogenesis in pneumonia following M. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986276      PMCID: PMC119980          DOI: 10.1128/cdli.9.3.669-676.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Development of a germfree mouse model of Vibrio cholerae infection.

Authors:  J R Butterton; E T Ryan; R A Shahin; S B Calderwood
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Immunologic aspects of experimental Mycoplasma pneumoniae infection.

Authors:  G W Fernald
Journal:  J Infect Dis       Date:  1969-03       Impact factor: 5.226

3.  Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases.

Authors:  H M Foy; H Ochs; S D Davis; G E Kenny; R R Luce
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

4.  T lymphocyte responses of murine lung: immunization with alloantigen induces accumulation of cytotoxic and other T lymphocytes in the lung.

Authors:  M C Liu; K Ishizaka; M Plaut
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

Review 5.  The gnotobiotic animal as a tool in the study of host microbial relationships.

Authors:  H A Gordon; L Pesti
Journal:  Bacteriol Rev       Date:  1971-12

Review 6.  Models of mycoplasma respiratory and genital tract infections.

Authors:  H Brunner
Journal:  Wien Klin Wochenschr       Date:  1997-08-08       Impact factor: 1.704

7.  Enhancement of cytotoxicity of active macrophages by mycoplasma: role of mycoplasma-associated induction of tumor necrosis factor-alpha (TNF-alpha) in macrophages.

Authors:  S Arai; M Furukawa; T Munakata; K Kuwano; H Inoue; T Miyazaki
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

8.  Tuberculin anergy in patients with Mycoplasma pneumoniae infection.

Authors:  G Biberfeld; G Sterner
Journal:  Scand J Infect Dis       Date:  1976

9.  Open lung biopsy in Mycoplasma pneumoniae pneumonia.

Authors:  S Rollins; T Colby; F Clayton
Journal:  Arch Pathol Lab Med       Date:  1986-01       Impact factor: 5.534

View more
  12 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 2.  Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.

Authors:  Klara Kubelkova; Milota Benuchova; Hana Kozakova; Marek Sinkora; Zuzana Krocova; Jaroslav Pejchal; Ales Macela
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

3.  Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

Authors:  C M Salvatore; M Fonseca-Aten; K Katz-Gaynor; A M Gomez; A Mejias; C Somers; S Chavez-Bueno; G H McCracken; R D Hardy
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

4.  Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Authors:  Ana María Ríos; Asunción Mejías; Susana Chávez-Bueno; Mónica Fonseca-Aten; Kathy Katz; Jeanine Hatfield; Ana María Gómez; Hasan S Jafri; George H McCracken; Octavio Ramilo; Robert Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

5.  Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.

Authors:  C M Salvatore; M Fonseca-Aten; K Katz-Gaynor; A M Gomez; R D Hardy
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

6.  Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model.

Authors:  Takeshi Saraya; Koh Nakata; Kazuhide Nakagaki; Natsuki Motoi; Kuniko Iihara; Yasunori Fujioka; Teruaki Oka; Daisuke Kurai; Hiroo Wada; Haruyuki Ishii; Haruhiko Taguchi; Shigeru Kamiya; Hajime Goto
Journal:  Results Immunol       Date:  2011-11-11

Review 7.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

8.  Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia.

Authors:  Shenggang Ding; Xiaowu Wang; Wei Chen; Yuan Fang; Boyu Liu; Yan Liu; Guanghe Fei; Linding Wang
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  Differential expression of lipoprotein genes in Mycoplasma pneumoniae after contact with human lung epithelial cells, and under oxidative and acidic stress.

Authors:  Katri M Hallamaa; Sen-Lin Tang; Nino Ficorilli; Glenn F Browning
Journal:  BMC Microbiol       Date:  2008-07-23       Impact factor: 3.605

10.  Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children.

Authors:  Mingyue Yang; Fanzheng Meng; Kuo Wang; Man Gao; Ruihua Lu; Mengyao Li; Fangxing Zhao; Lijuan Huang; Yining Zhang; Genhong Cheng; Xiaosong Wang
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.